Irvine, California — KB Medical Group (KBMED), a global leader in medical device innovation and manufacturing, has announced the expansion of its production capacity with a new Safety Pen-Type Blood Collection Needle (Model: SBCN-3)  line, scheduled to begin mass production in November 2025. This milestone marks a major investment in enhancing supply stability for Europe’s laboratory and hospital sectors, where the demand for safety-engineered blood collection devices continu

I rvine, California — KB Medical Group (KBMED) is proud to announce the successful shipment and delivery of a full 40-foot high-quality...

A t KB Medical Group (KBMED), we understand that families, home caregivers, and healthcare professionals are seeking solutions that...

I n our previous discussions, we explored the three key pressure technologies in Needle-Free Connectors (NFCs) : positive, negative, and...

I n high-volume clinical settings, safety is not just a feature—it’s a requirement. That’s why at KBMED , we continue to align product...

Building on its earlier announcement of Securing DGDA certification in Bangladesh , KBMED, a U.S.-based leader in enteral feeding...

KBMED is proud to announce the launch of its latest infection prevention product: the Disinfection Cap for Needleless Connectors ,...

Following a focused two-day business visit to El Salvador, Panda. W, Deputy Sales Manager and Regional Manager for North & South America,...

KBMED  proudly unveils its upgraded  Push Button Blood Collection Set , engineered to meet the high standards expected by today’s...

As clinical demand rises across Central America, KBMED is strengthening its presence in El Salvador, providing both specimen collection...

KBMED  Headquarters — At the end of June, a senior delegation from Venezuela concluded a multi-site tour across KBMED 's manufacturing...

KBMED is expanding its role in supporting global enteral safety by delivering customized ENFit® components to OEM partners worldwide. As...

July 2025, We are proud to announce that KB Medical Group ( www.kbmed.com ) has completed a rigorous on-site audit conducted by the U.S....

June 2025 – KB Medical (KBMED) is proud to announce that it recently received a Canadian order for our specimen product line, as we...

June 2025 – California, USA / Dhaka, Bangladesh — KBMED, a global leader in high-performance medical technology, proudly announces that...

R ecent developments in U.S. trade policy have significantly impacted Europe's medical disposable market. On April 9, 2025, President...

KBMED proudly announces that our single-use sterile syringes and safety needles have completed rollout across Spain’s national pharmacy...

Needle-free medical solution devices are designed to deliver medication or draw blood without using traditional needles, enhancing...

In modern healthcare, infusion therapy remains critical to patient care, requiring safe, efficient, and contamination-free medication...

KB Medical Group  proudly announces that its blood collection tubes have successfully transitioned from the EU In Vitro Diagnostic...